Drug Shortage Report for MINT-SOLIFENACIN
Report ID | 35492 |
Drug Identification Number | 02443171 |
Brand name | MINT-SOLIFENACIN |
Common or Proper name | Solifenacin |
Company Name | MINT PHARMACEUTICALS INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | SOLIFENACIN SUCCINATE |
Strength(s) | 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 90 Count Bottles |
ATC code | G04BD |
ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-01-09 |
Actual start date | 2018-01-09 |
Estimated end date | 2018-02-28 |
Actual end date | 2018-03-20 |
Shortage status | Resolved |
Updated date | 2018-03-21 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2018-03-21 | French | Compare |
v4 | 2018-03-21 | English | Compare |
v3 | 2018-01-10 | English | Compare |
v2 | 2018-01-09 | French | Compare |
v1 | 2018-01-09 | English | Compare |
Showing 1 to 5 of 5